Koya Medical (“Koya”), an emerging medtech innovator advancing patient-centered solutions in vascular health, has announced its participation in the Stifel 2025 Healthcare Conference on Thursday, November 13, 2025 at 4:00pm EST at the Lotte New York Palace Hotel, 4th Floor Holmes II.
https://mma.prnewswire.com/media/2707057/Koya_Medical_Logo.jpg
CEO Andy Doraiswamy will discuss the company's latest clinical research, strategic growth plans, commercialization progress of its products including Dayspring® non-pneumatic compression for chronic edema, and pipeline for comprehensive vascular solutions across the care continuum.
Conference attendees can engage with Koya through one-on-one networking sessions to learn more.
About Koya Medical
Founded in 2018 and headquartered in Dallas, Koya Medical is redefining vascular health with patient-centered solutions designed to support care from clinic to home. Inspired by a personal journey with vascular disease, Koya's mission is to close treatment gaps -starting with its FDA-cleared Dayspring treatment system and advancing its pipeline.
Why Vascular Health Matters
More than 35 million Americans live with venous and lymphatic diseases-serious yet often overlooked conditions that can severely impact mobility, quality of life, and long-term health-highlighting the urgent need for modern, evidence-based, and scalable solutions.
Learn more atwww.koyamedical.com and follow Koya onLinkedIn.
https://edge.prnewswire.com/c/img/favicon.png?sn=SF14975&sd=2025-11-06
View original content to download multimedia:https://www.prnewswire.com/news-releases/koya-medical-to-present-at-the-stifel-2025-healthcare-conference-in-new-york-302605503.html
SOURCE Koya Medical
https://rt.newswire.ca/rt.gif?NewsItemId=SF14975&Transmission_Id=202511060600PR_NEWS_USPR_____SF14975&DateId=20251106